Your browser doesn't support javascript.
loading
Dual mechanism: Epigenetic inhibitor apabetalone reduces SARS-CoV-2 Delta and Omicron variant spike binding and attenuates SARS-CoV-2 RNA induced inflammation.
Fu, Li; Gilham, Dean; Stotz, Stephanie C; Sarsons, Christopher D; Rakai, Brooke D; Tsujikawa, Laura M; Wasiak, Sylwia; Johansson, Jan O; Sweeney, Michael; Wong, Norman C W; Kulikowski, Ewelina.
Afiliação
  • Fu L; Resverlogix Corporation, Calgary, AB, Canada.
  • Gilham D; Resverlogix Corporation, Calgary, AB, Canada.
  • Stotz SC; Resverlogix Corporation, Calgary, AB, Canada.
  • Sarsons CD; Resverlogix Corporation, Calgary, AB, Canada.
  • Rakai BD; Resverlogix Corporation, Calgary, AB, Canada.
  • Tsujikawa LM; Resverlogix Corporation, Calgary, AB, Canada.
  • Wasiak S; Resverlogix Corporation, Calgary, AB, Canada.
  • Johansson JO; Resverlogix Corporation, Calgary, AB, Canada.
  • Sweeney M; Resverlogix Corporation, Calgary, AB, Canada.
  • Wong NCW; Resverlogix Corporation, Calgary, AB, Canada.
  • Kulikowski E; Resverlogix Corporation, Calgary, AB, Canada. Electronic address: ewelina@resverlogix.com.
Int Immunopharmacol ; 117: 109929, 2023 Apr.
Article em En | MEDLINE | ID: mdl-36857935
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article